Humoral immune response profiling with peptide microarrays

by Reimer U, Wenschuh H, Baden LR, Pau M, Weijtens M, Barouch DH
Published 2012-09-01

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine

by Walsh SR, Seaman MS, Johnson JA, Tucker RP, Krause KH, Weijtens M, Pau MG, Goudsmit J, Dolin R, Barouch DH, Baden LR
Published 2012-09-01